Total Payments
$1,707
2022 Payments
$109.41
Companies
20
Transactions
46
Medicare Patients
2,202
Medicare Billing
$234,712
Payment Breakdown by Category
Food & Beverage$1,707 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,707 | 46 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $542.24 | 17 | $0 (2022) |
| Amgen Inc. | $196.80 | 6 | $0 (2020) |
| Boston Scientific Corporation | $151.88 | 2 | $0 (2022) |
| AtriCure, Inc. | $98.44 | 1 | $0 (2017) |
| Abbott Laboratories | $95.58 | 2 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $95.45 | 1 | $0 (2017) |
| Neurocrine Biosciences, Inc. | $95.23 | 1 | $0 (2019) |
| Impulse Dynamics (USA) Inc. | $87.80 | 1 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $80.28 | 1 | $0 (2017) |
| Cardinal Health 200, LLC | $53.33 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $109.41 | 3 | Boston Scientific Corporation ($68.57) |
| 2021 | $292.00 | 9 | Impulse Dynamics (USA) Inc. ($87.80) |
| 2020 | $55.53 | 3 | Novartis Pharmaceuticals Corporation ($31.91) |
| 2019 | $314.86 | 10 | Neurocrine Biosciences, Inc. ($95.23) |
| 2018 | $219.24 | 6 | Novartis Pharmaceuticals Corporation ($128.69) |
| 2017 | $716.17 | 15 | Novartis Pharmaceuticals Corporation ($193.86) |
All Payment Transactions
46 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/01/2022 | Boston Scientific Corporation | LUX-Dx Insertable Cardiac Monitor (Device) | Food and Beverage | In-kind items and services | $68.57 | General |
| Category: LUX-Dx_CRM | ||||||
| 02/01/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/25/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/20/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/20/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/22/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $21.72 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/08/2021 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/25/2021 | Merck Sharp & Dohme Corporation | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $13.11 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/13/2021 | Abbott Laboratories | Confirm Rx (Device) | Food and Beverage | In-kind items and services | $81.70 | General |
| Category: Cardiac Rhythm Management | ||||||
| 05/12/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/12/2021 | Impulse Dynamics (USA) Inc. | Optimizer Smart System (Device) | Food and Beverage | In-kind items and services | $87.80 | General |
| Category: Cardiovascular Device | ||||||
| 03/29/2021 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/28/2020 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: Cardiology | ||||||
| 01/24/2020 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/03/2020 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/19/2019 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $95.23 | General |
| Category: NEUROLOGY | ||||||
| 08/16/2019 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: Cardiology | ||||||
| 07/10/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/07/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $12.42 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/17/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/13/2019 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Cardiology | ||||||
| 04/10/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/01/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $12.91 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/30/2019 | Boston Scientific Corporation | WATCHMAN (Device) | Food and Beverage | In-kind items and services | $83.31 | General |
| Category: STRUCTURAL HEART | ||||||
| 01/10/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 71 | 81 | $19,623 | $5,157 |
| 2022 | 1 | 25 | 29 | $7,939 | $2,323 |
| 2021 | 19 | 2,106 | 2,541 | $568,579 | $227,232 |
Total Patients
2,202
Total Services
2,651
Medicare Billing
$234,712
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 38 | 46 | $12,701 | $3,529 | 27.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 22 | 24 | $4,334 | $1,077 | 24.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 11 | 11 | $2,587 | $551.00 | 21.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 25 | 29 | $7,939 | $2,323 | 29.3% |
| 93229 | Heart rhythm tracing, computer analysis, physician prescribed transmission of patient-triggered events greater than 24-hour ekg up to 30 days | Office | 2021 | 105 | 106 | $141,534 | $57,802 | 40.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 284 | 376 | $93,813 | $37,950 | 40.5% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2021 | 222 | 226 | $92,583 | $35,424 | 38.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 171 | 171 | $56,043 | $21,883 | 39.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 166 | 218 | $39,240 | $15,540 | 39.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 82 | 82 | $33,907 | $14,132 | 41.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 55 | 56 | $18,717 | $7,846 | 41.9% |
| 78492 | Multiple nuclear medicine studies of blood flow in heart muscle at rest and with stress | Office | 2021 | 115 | 115 | $18,245 | $7,748 | 42.5% |
| 93298 | Remote evaluations of heart rhythm monitor system implanted under skin with qualified health care professional analysis, review, and report, up to 30 days | Office | 2021 | 131 | 301 | $15,953 | $6,294 | 39.5% |
| 93880 | Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck | Office | 2021 | 29 | 30 | $11,584 | $4,685 | 40.4% |
| 93297 | Remote evaluations of implantable heart and blood vessel monitor system with qualified health care professional analysis, review, and report, up to 30 days | Office | 2021 | 64 | 160 | $8,480 | $3,347 | 39.5% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 272 | 278 | $8,792 | $3,150 | 35.8% |
| 93294 | Remote evaluations of single, dual, or multiple lead pacemaker system with qualified health care professional analysis, review, and report, up to 90 days | Office | 2021 | 94 | 100 | $6,000 | $2,408 | 40.1% |
| 93228 | Heart rhythm tracing, computer analysis, and interpretation of patient-triggered events greater than 24-hour ekg up to 30 days | Office | 2021 | 105 | 106 | $5,406 | $2,175 | 40.2% |
| 93923 | Ultrasound study of arteries of both arms and legs, complete | Office | 2021 | 18 | 18 | $4,722 | $1,857 | 39.3% |
| 93224 | Heart rhythm tracing, analysis, and interpretation of 48-hour ekg, includes recording, scanning analysis with report | Office | 2021 | 28 | 29 | $4,826 | $1,668 | 34.6% |
| 93018 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report | Office | 2021 | 115 | 115 | $3,360 | $1,327 | 39.5% |
| 93295 | Remote evaluations of defibrillator up to 90 days with analysis, review and report | Office | 2021 | 32 | 36 | $2,700 | $1,044 | 38.7% |
| 93015 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report | Office | 2021 | 18 | 18 | $2,674 | $952.19 | 35.6% |
About Dr. Peter Gregor, MD
Dr. Peter Gregor, MD is a Cardiovascular Disease healthcare provider based in Owensboro, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1528021235.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Gregor, MD has received a total of $1,707 in payments from pharmaceutical and medical device companies, with $109.41 received in 2022. These payments were reported across 46 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,707).
As a Medicare-enrolled provider, Gregor has provided services to 2,202 Medicare beneficiaries, totaling 2,651 services with total Medicare billing of $234,712. Data is available for 3 years (2021–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Owensboro, KY
- Active Since 04/11/2006
- Last Updated 01/27/2016
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1528021235
Products in Payments
- ENTRESTO (Drug) $501.40
- Repatha (Biological) $176.46
- ELIQUIS (Drug) $108.76
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX, MODELS (Device) $98.44
- INGREZZA (Drug) $95.23
- Optimizer Smart System (Device) $87.80
- WATCHMAN (Device) $83.31
- Confirm Rx (Device) $81.70
- BRILINTA (Drug) $80.28
- LUX-Dx Insertable Cardiac Monitor (Device) $68.57
- Mozec NC PTCA Balloon (Device) $53.33
- ZONTIVITY (Drug) $48.87
- XARELTO (Drug) $46.62
- LEQVIO (Drug) $40.84
- PRALUENT (Drug) $23.34
- Corlanor (Drug) $20.34
- Mitra Clip system (Device) $13.88
- Definity (Drug) $13.15
- VERQUVO (Drug) $13.11
- LifeVest (Device) $8.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Owensboro
Kebede Shire, M.d, M.D
Cardiovascular Disease — Payments: $6,216
Cardiovascular Disease $6,216
Tseday Sirak, M.d, M.D
Cardiovascular Disease — Payments: $5,407
Cardiovascular Disease $5,407
Dr. Stephen Moore, D.o, D.O
Cardiovascular Disease — Payments: $4,830
Cardiovascular Disease $4,830
Johnny Makhoul, Md, MD
Cardiovascular Disease — Payments: $3,601
Cardiovascular Disease $3,601
Dr. Michael Kelley, M.d, M.D
Cardiovascular Disease — Payments: $943.86
Cardiovascular Disease $943.86
Jessica Sheridan-Babare, Do, DO
Cardiovascular Disease — Payments: $878.20
Cardiovascular Disease $878.20